- Home
- RBOT vs ICCM Comparison
RBOT vs ICCM Comparison
Compare RBOT & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RBOT | ICCM |
|---|---|---|
| Founded | 2014 | 2006 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Medical Specialities | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.9M | 43.4M |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | RBOT | ICCM |
|---|---|---|
| Price | $2.02 | $0.64 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $7.00 | $2.50 |
| AVG Volume (30 Days) | 61.7K | ★ 169.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $19.87 |
| Revenue Next Year | N/A | $31.38 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.71 | $0.54 |
| 52 Week High | $13.75 | $1.53 |
Technical Indicators
Market Signals| Indicator | RBOT | ICCM |
|---|---|---|
| Relative Strength Index (RSI) | 45.38 | 55.18 |
| Support Level | $1.76 | $0.59 |
| Resistance Level | $2.41 | $0.74 |
| Average True Range (ATR) | 0.20 | 0.03 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 38.63 | 73.86 |
Price Performance
Historical ComparisonAbout RBOT Vicarious Surgical Inc.
Vicarious Surgical Inc designs a surgical robot that enables surgeons to perform minimally invasive surgery with 3D visualization and accurate control. Its Vicarious Surgical Robotic System is designed with a focus on abdominal access and visualization through a single port. The company has following segment: Research and development, Sales and marketing, General and administrative.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.